Dolby Laboratories, Inc.
DLB · NYSE
9/26/2025 | 6/27/2025 | 3/28/2025 | 12/27/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $702 | $699 | $750 | $612 |
| Short-Term Investments | $1 | $1 | $0 | $0 |
| Receivables | $512 | $502 | $544 | $560 |
| Inventory | $30 | $32 | $35 | $32 |
| Other Curr. Assets | $115 | $78 | $28 | $50 |
| Total Curr. Assets | $1,388 | $1,338 | $1,389 | $1,286 |
| Property Plant & Equip (Net) | $504 | $511 | $507 | $513 |
| Goodwill | $530 | $529 | $525 | $520 |
| Intangibles | $397 | $408 | $412 | $421 |
| Long-Term Investments | $80 | $78 | $74 | $86 |
| Tax Assets | $214 | $229 | $223 | $227 |
| Other NC Assets | $114 | $103 | $99 | $105 |
| Total NC Assets | $1,839 | $1,858 | $1,840 | $1,873 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,228 | $3,196 | $3,229 | $3,159 |
| Liabilities | – | – | – | – |
| Payables | $18 | $17 | $17 | $12 |
| Short-Term Debt | $0 | $0 | $11 | $11 |
| Tax Payable | $9 | $7 | $13 | $21 |
| Deferred Revenue | $31 | $36 | $40 | $37 |
| Other Curr. Liab. | $107 | $85 | $293 | $293 |
| Total Curr. Liab. | $438 | $389 | $457 | $442 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $30 | $29 | $30 | $32 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $100 | $136 | $129 | $134 |
| Total NC Liab. | $158 | $193 | $189 | $200 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $39 | $39 | $40 | $44 |
| Total Liabilities | $596 | $582 | $646 | $642 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $2,635 | $2,618 | $2,602 | $2,543 |
| AOCI | -$13 | -$14 | -$28 | -$36 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $2,623 | $2,605 | $2,574 | $2,508 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $9 | $10 | $9 | $9 |
| Total Liab. & Tot. Equity | $3,228 | $3,196 | $3,229 | $3,159 |
| Net Debt | -$702 | -$699 | -$740 | -$600 |